Indivior Pharmaceuticals (INDV) Gross Profit (2024 - 2026)
Indivior Pharmaceuticals' Gross Profit came in at $294 million for Q2 2026, up 17.6% from $250 million a year earlier and up 6.1% from the prior quarter.
Powered by 
Analysis
Indivior Pharmaceuticals (INDV) Gross Profit (2024 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Indivior Pharmaceuticals reported Gross Profit of $1.09 billion, up 13.6% year-over-year; for FY2025, it was $994 million, up 3.9% from FY2024.
- Gross Profit has increased in each of the last four years, with a four-year compound annual growth rate of 10.6% (FY2021 to FY2025).
- Going back by year, Gross Profit was $957 million in FY2024 (+4.1%), $919 million in FY2023 (+22.7%), $749 million in FY2022 (+12.8%) and $664 million in FY2021.
- The Q2 2026 figure represents the highest quarterly Gross Profit in data going back to Q1 2024.
- Year-over-year, Gross Profit has increased for three consecutive quarters, with growth averaging 9.8% over the last six quarters.
- Business Quant data shows INDV's Gross Profit at $277 million (Q1 2026), $292 million (Q4 2025) and $230 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Indivior Pharmaceuticals | 4.21 Bn | 3.18 Bn | 294.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 294.00 Mn |
| Mar 31, 2026 | 277.00 Mn |
| Dec 31, 2025 | 292.00 Mn |
| Sep 30, 2025 | 230.00 Mn |
| Jun 30, 2025 | 250.00 Mn |
| Mar 31, 2025 | 221.00 Mn |
| Dec 31, 2024 | 250.00 Mn |
| Sep 30, 2024 | 241.00 Mn |
| Jun 30, 2024 | 220.00 Mn |
| Mar 31, 2024 | 246.00 Mn |
API Access
Indivior Pharmaceuticals Gross Profit API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-profit&ticker=INDV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-profit", "ticker": "INDV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-profit&ticker=INDV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();